Research into 5-Amino-1MQ has been conducted primarily in preclinical (animal and cellular) models, and it has not been approved by the MHRA, NICE, or any major regulatory authority for human therapeutic use
Additionally, the specificity of these results to the NNMTi 5A-1MQ and the dosage used herein also require further evaluation
[3] [2] The cardiovascular impact of 5-Amino-1MQ in humans is entirely unknown
Many find TB-500 easier due to less frequent injection
However, their fusion peptide, MPGA, exerted strong tumor cell killing activity by destroying the cell membranes
It is a precise biological signal that activates your bodys own repair systems with remarkable specificity and a safety profile that distinguishes it from most conventional treatments